Fraud Case Involved Privacy Violations

Drug Company Novo Nordisk Agrees to $1.7 Million Settlement
Fraud Case Involved Privacy Violations
Danish pharmaceutical company Novo Nordisk Inc. has entered a $1.725 million civil settlement agreement to resolve allegations that the company accessed and misused private patient information and filed false or fraudulent Medicaid claims.

The drug company agreed to the civil settlement with the United States and several states, according to Loretta Lynch, U.S. Attorney for the Eastern District of New York.

The civil settlement agreement alleges the drug company's sales representatives made payments to Rite Aid pharmacists in exchange for them recommending two diabetes drugs. The pharmacists, together with Novo Nordisk sales representatives, identified patients who were candidates for the drugs and communicated with physicians, patients and other pharmacists to encourage them to use or recommend the use of the drugs, according to the agreement.

"As part of these activities, the pharmacists accessed, or allowed Novo Nordisk representatives to access, confidential patient information, which was used for the purpose of conducting marketing events that were designed to switch patients from competitor diabetes drugs ...," according to a statement from the U.S. attorney.

In addition to entering the civil settlement, the company, which has not admitted to engaging in the conduct, also has entered into a "corporate integrity agreement" with the Department of Health and Human Services, Office of the Inspector General.


About the Author

Howard Anderson

Howard Anderson

News Editor, ISMG

Anderson is news editor of Information Security Media Group and was founding editor of HealthcareInfoSecurity and DataBreachToday. He has more than 40 years of journalism experience, with a focus on healthcare information technology issues. Before launching HealthcareInfoSecurity, he served as founding editor of Health Data Management magazine, where he worked for 17 years, and he served in leadership roles at several other healthcare magazines and newspapers.




Around the Network

Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing inforisktoday.asia, you agree to our use of cookies.